🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The pharmacokinetics of 50 mg BIBR 1048 administered as two newly developed...
Status
Completed
Location
Multiple Locations
Start Date
2001-04
Trial ID
NCT02170805
To assess the steady state pharmacokinetic profile of BIBR 953 ZW after adm...
Status
Completed
Location
Multiple Locations
Start Date
2002-11
Trial ID
NCT02173730
Treatments Being Tested
To assess the extent of absorption of 150 mg of BIBR 1048 administered as c...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT02170610
Treatments Being Tested
Study to assess the amount of BIBR 953 ZW in urine and concentrations in pl...
Status
Completed
Location
Multiple Locations
Start Date
2002-02
Trial ID
NCT02170623
Treatments Being Tested
Study to assess the amount of BIBR 953 ZW in urine after administration of ...
Status
Completed
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT02170636
To assess the amount of BIBR 953 ZW in urine of 50 mg of BIBR 1048 bid over...
Status
Completed
Location
Multiple Locations
Start Date
2001-10
Trial ID
NCT02170896
To assess safety, pharmacokinetics and the effect of BIBR 1048 MS on coagul...
Status
Completed
Location
Multiple Locations
Start Date
1999-11
Trial ID
NCT02170740
Treatments Being Tested
To assess the extend of absorption of 12.5, 25, 50 and 100 mg of BIBR 1048 ...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT02170766
Treatments Being Tested